Antivirals and neutralising monoclonal antibodies in the treatment of Covid-19 in hospitalised Patients

A COVID-19 therapeutic alert has been issued: neutralising monoclonal antibodies (nMABs) and antivirals for treatment of Covid-19 hospitalised patients.

The policy has been updated to reflect the withdrawal of the casirivimab and imdevimab (Ronapreve) neutralising monoclonal antibody (nMAB) combination as a treatment option for patients hospitalised due to symptoms of COVID-19.

Further information and actions can be found in the COVID-19 therapeutic alert and interim clinical commissioning policy on the CAS alert website

Spread the cost of your membership

With the recent cost of living rises, we’re all making savings wherever we can – and you can do the same with your RPS membership.

Instead of paying for everything all at once, make life easier by paying monthly. After all, you use your RPS membership benefits all year round, so it makes sense to pay for them the same way.

With monthly Direct Debit, you only have a small, regular payment each month. It’s the easy way to keep practicing at your best, without making a hole in your finances!

Spread the cost of your membership - join by monthly Direct Debit today.

Support Alert

Spread the cost of your membership